Showing results (31-40 of 424) with videos related to
Sort By:
Pageof 43
Schizophrenia Bulletin|July 10, 2007
Molecular targets for treating cognitive dysfunction in schizophreniaJohn A Gray, Bryan L RothTrends in Pharmacological Sciences|March 12, 2003
Salvinorin A: the "magic mint" hallucinogen finds a molecular target in the kappa opioid receptorDouglas J Sheffler, Bryan L RothThe Journal of Clinical Investigation|December 3, 2013
Lorcaserin and pimavanserin: emerging selectivity of serotonin receptor subtype-targeted drugsHerbert Y Meltzer, Bryan L RothBrain Research|October 16, 2012
Pharmacosynthetics: Reimagining the pharmacogenetic approachMartilias S Farrell, Bryan L RothMolecular Cell|July 21, 2023
Built-in functional selectivity in neurons is mediated by the neuronal protein, GINIPNicholas J Kapolka, Bryan L RothAnnual Review of Neuroscience|July 9, 2014
Chemogenetic tools to interrogate brain functionsScott M Sternson, Bryan L RothStructure (London, England : 1993)|August 5, 2022
Structural insights from G-protein-coupled receptor complexes enable the rational engineering of improved light-activated designer receptorsNicholas J Kapolka, Bryan L RothThe Journal of Biological Chemistry|June 24, 2015
Integrated Approaches for Genome-wide Interrogation of the Druggable Non-olfactory G Protein-coupled Receptor SuperfamilyBryan L Roth, Wesley K KroezeNeuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 25, 2008
Opportunities and challenges of psychiatric drug discovery: roles for scientists in academic, industry, and government settingsP Jeffrey Conn, Bryan L RothPageof 43